National Drug Code (NDC) Level Information Data

A vital part of FDA and CDER’s mission is to promote and protect the public health. Offices within CDER take a variety of approaches to meet these broad goals. For example, the Office of Surveillance and Epidemiology (OSE) evaluates drug risks and promotes the safe use of drugs by the American people. The Division of Medication Error, Prevention and Analysis (DMEPA) aims to increase the safe use of drug products by minimizing use error that is related to the naming, labeling, product design, or packaging of drug products with the goal of eliminating medication errors in the United States healthcare system.

The Contractor shall provide FDA personnel with: Real-time, unlimited, immediate, direct, multi-user, desktop access to current and previously existing, commercially available NDC-level information data and The ability to use these data to integrate into other data resources and analyses to describe product characteristics.